Cytek Biosciences (CTKB) Asset Utilization Ratio (2021 - 2026)

Cytek Biosciences' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.45 for Q1 2026.

• Quarterly Asset Utilization Ratio rose 11.74% year-over-year to 0.45 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.45 (up 11.74% YoY) and the FY2025 annual result came in at 0.42, up 3.96% from the prior year.
• Asset Utilization Ratio was 0.45 for Q1 2026 at Cytek Biosciences, up from 0.42 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.45 in Q1 2026 and bottomed at 0.29 in Q1 2022.
• A 5-year average of 0.37 and a median of 0.4 in 2025 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio retreated 10.86% — and 2024, when it grew 27.96%.
• Cytek Biosciences' Asset Utilization Ratio stood at 0.32 in 2022, then advanced by 18.23% to 0.38 in 2023, then grew by 6.28% to 0.4 in 2024, then rose by 4.12% to 0.42 in 2025, then gained by 6.43% to 0.45 in 2026.
• Business Quant data shows CTKB's Asset Utilization Ratio at 0.45 in Q1 2026, 0.42 in Q4 2025, and 0.4 in Q3 2025.